Prio Wealth Limited Partnership Organon & Co. Transaction History

Prio Wealth Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $205,757 - $252,540	-8,827 Reduced 52.91%	7,856 $0
Q3 2022 Feb 27, 2023	SELL	$23.4 - $34.25 $21,083 - $30,859	-901 Reduced 9.05%	9,058 $211,000
Q2 2022 Feb 27, 2023	BUY	$31.66 - $38.9 $66,580 - $81,806	2,103 Added 26.77%	9,959 $336,000
Q1 2022 Feb 21, 2023	BUY	$30.45 - $39.36 $152,341 - $196,918	5,003 Added 63.68%	12,859 $449,000
Q4 2021 Feb 17, 2022	SELL	$28.67 - $37.13 $238,419 - $308,773	-8,316 Reduced 33.27%	16,683 $508,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $988,107 - $1.23 Million	-34,513 Reduced 57.99%	24,999 $820,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $1.69 Million - $2.26 Million	59,512 New	59,512 $1.8 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Prio Wealth Limited Partnership with notifications on news.